HELP Cybin Inc.
Company Analysis
Latest News
🟢 Cybin is trading 8.6% up in pre-market with no clear catalyst identified
Cybin is trading at $11.98, up +8.63%, with the cause of the October 13 pre-market rise unclear. - No fresh company announcement or reliable report was...
🔴 Cybin is trading 5% down on October 12, 2026 — no clear catalyst identified
Cybin is trading at $11.20, down 5.08% during the October 12 session, with no clear company-specific or broad-market catalyst identified. - No October 12...
🟢 Cybin is trading 11% up with no clear company-specific catalyst
Cybin is trading 10.68% up at $11.87 on October 9, 2026, with no clear company-specific announcement explaining the move. - The latest company news is an...
🟢 Cybin is trading 5% up
Cybin is trading up 5.32% at $11.29 on October 9, 2026, with no reported company-specific announcement clearly explaining the intraday gain. - The latest...
🔴 Cybin is trading 6.6% down today amid biotech-sector weakness
Cybin is trading 6.6% down at $10.67, with biotech-sector weakness potentially weighing on shares. - No clear company-specific catalyst for October 6 has...
🟢 Cybin is trading 7% up in pre-market
Cybin is trading 7.07% higher in pre-market at $13.48, versus its September 28 close of $12.59; no confirmed company-specific catalyst was identified. -...
🟢 Cybin is trading 5.19% up in pre-market after HLP003 12-month efficacy data
Cybin is trading 5.19% higher at $13.24 after 12-month HLP003 efficacy data in major depressive disorder were presented at Psychiatry Congress 2026. - The...
🔴 Cybin is trading 5.38% down today as biotech stocks fall with broader markets
Cybin is trading 5.38% lower at $12.32 as broader market weakness pressured biotechnology and growth stocks. - The Nasdaq Composite is down 0.73%, while...
🔴 Cybin is trading 5.4% down today amid broader risk-off conditions
Cybin is trading at $12.97 (-5.39%) amid broader risk-off conditions. - On September 23, 2026, the Nasdaq was down 0.94% and the S&P 500 was down 0.55%. - No...
🟢 Cybin is trading 5% up in pre-market after four HLP003 presentations at Psych Congress 2026
Cybin is trading at $14.37, up 5.21% after releasing four HLP003 research presentations at Psych Congress 2026. - Analyses included 12-month efficacy findings...
Helus Pharma Pops 11% on Depression Drug Data Blitz, but Can It Keep Up in a Crowding Psychedelic Race?
Shares shifted sharply higher Monday as Helus Pharma (ticker: HELP), the company formerly known as Cybin, unveiled four research presentations at Psych...
🟢 Cybin is trading 10.75% up today after four HLP003 presentations at Psych Congress 2026
Cybin is trading 10.75% up at $13.70 after announcing four HLP003 poster presentations at Psych Congress 2026. - Presentations include updates from its Phase...
🟢 Cybin is trading 5.94% up today as major U.S. indexes gained more than 0.5%
Cybin is trading 5.94% up now at $13.11 after opening on September 21, 2026, likely reflecting a broader risk-on backdrop as major U.S. indexes gained more...
🔴 Cybin is trading 10.7% down today
Cybin is trading at $12.52 (-10.70%) with no confirmed company-specific catalyst identified for September 18, 2026. - The September 16 Morgan Stanley...
🔴 Cybin is trading 6.78% down today — no clear catalyst identified
Cybin is trading 6.78% down at $13.07, with no clear company-specific announcement identified for September 18, 2026. - Its September 16 Morgan Stanley...
🟢 Cybin is trading 6.35% up in pre-market amid broad risk-on sentiment
Cybin is trading 6.35% up at $14.91 in pre-market, apparently amid broad risk-on sentiment rather than a new company-specific announcement. - Cybin advanced...
🟢 Cybin is trading 13.5% up in after-hours trading amid broad risk-on rally
Cybin is trading 13.54% up at $15.92 after regular-session trading ended at $14.02 on September 17, 2026, amid a broad risk-on rally. - The S&P 500 rose...
🟢 Cybin is trading 5% up in after-hours trading as S&P 500 and Nasdaq advanced
Cybin is trading at $14.77 (+5.35%) after broader market gains, with the S&P 500 up 1.05% and Nasdaq up 1.68%. • Regular-session trading ended at $14.01 on...
🟢 Cybin is trading 5% up today
Cybin is trading at $13.63, up 5.13% after rising from its September 11 close of $12.97. • No company-specific news release or clinical milestone was reported...
🔴 Cybin is trading 5.1% down today after hotter-than-expected August producer-price inflation
Cybin is trading 5.1% down at $12.98 after broader U.S. equity weakness following hotter-than-expected August producer-price inflation and rising Treasury...